Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Colorectal Neoplasms 22Neoplasms 13Colonic Neoplasms 10Breast Neoplasms 10Venous Thromboembolism 8Prostatic Neoplasms 8Multiple Myeloma 7Recurrence 6Polycythemia Vera 6Carcinoma, Non-Small-Cell Lung 6Thrombocythemia, Essential 4Neoplasms, Plasma Cell 4Ovarian Neoplasms 3Neoplasm Metastasis 3Melanoma 3Thrombosis 2Sarcoma 2Rectal Neoplasms 2Primary Myelofibrosis 2Pancreatic Neoplasms 2Neoplastic Cells, Circulating 2Neoplasms by Site 2Myocardial Infarction 2Lung Neoplasms 2Intestinal Neoplasms 2Intestinal Diseases 2Inflammation 2Gastrointestinal Neoplasms 2Fallopian Tube Neoplasms 2Esophageal Neoplasms 2

Interventions

Dalteparin 9apixaban 7Tinzaparin 5Enoxaparin 5Rivaroxaban 3Dabigatran 3Warfarin 2Heparin, Low-Molecular-Weight 2Fondaparinux 2perflutren 1enoxaparin sodium 1edoxaban 1bemiparin 1Sulfur Hexafluoride 1Rosuvastatin Calcium 1Phenprocoumon 1Nephrectomy 1Nadroparin 1Hospitals 1Heparin 1Fluorodeoxyglucose F18 1Educational Status 1Deoxyribonucleases 1Aspirin 1Acenocoumarol 14-((1,4,8,11-tetraazacyclotetradec-1-yl)methyl)benzoic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Pulmonary Embolism × Aspirin × Clear all
NCT01727427 2019-08-08

Prospective Study on the Treatment of Unsuspected Pulmonary Embolism in Cancer Patients

G. d'Annunzio University

Completed
695 enrolled

Neoplasms, Pulmonary Embolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡